CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...

The Super Specialty Hospital (SSH) administration here has claimed to have achieved a medical milestone by performing CAR ...

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...

The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor (CAR) T-cell therapy ...

The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy ...

India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...

India faces a rising burden of blood cancers, with around 120,000 new cases and over 70,000 deaths annually from leukemia, ...

Unlike CAR-T cells, NK cells don’t need genetic modification to recognize a specific threat — they act broadly without ...